An update on the presence of psychiatric comorbidities in acne patients, Part 2: Depression, anxiety, and suicide

Cutis

Volumn 88, Issue 2, 2011, Pages 92-97

  Saitta, Peter ^a   Keehan, Patrick ^b   Yousif, James ^c   Way, Bill V ^b   Grekin, Steven ^a   Brancaccio, Ronald ^d  

^a Oakwood Southshore Medical Center   (United States)

^b A T STILL UNIVERSITY   (United States)

^c MICHIGAN STATE UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DERMATOLOGICAL AGENT; ISOTRETINOIN;

ACNE VULGARIS; ANXIETY DISORDER; BODY DYSMORPHIC DISORDER; DEPRESSION; HUMAN; MENTAL DISEASE; PSYCHOLOGICAL ASPECT; REVIEW; RISK; SUICIDAL IDEATION; SUICIDE;

ACNE VULGARIS; ANXIETY DISORDERS; BODY DYSMORPHIC DISORDERS; DEPRESSION; DERMATOLOGIC AGENTS; HUMANS; ISOTRETINOIN; MENTAL DISORDERS; RISK; SUICIDAL IDEATION; SUICIDE;

EID: 80053323922     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Saitta P, Keehan P, Yousif J, et al. An update on the presence of psychiatric comorbidities in acne patients, part 1: overview of prevalence. Cutis. 2011;88:33-40.
2. Mallon E, Newton JN, Klassen A. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol. 1999;140:672-676.
3. Sampogna F, Picardi A, Chren MM, et al. Association between poorer quality of life and psychiatric morbidity in patients with different dermatological conditions. Psychosom Med. 2004;66:620-624.
4. Hayashi N, Higaki Y, Kawamoto K, et al. A cross-sectional analysis of quality of life in Japanese acne patients using the Japanese version of Skindex-16. J Dermatol. 2004;31:971-976.
5. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect on treatment with isotretinoin. Br J Dermatol. 1999;140:273-282.
6. Krowchuk D, Stancin T, Keskinen R, et al. The psychosocial effects of acne on adolescents. Pediatr Dermatol. 1991;8:332-338.
7. Picardi A, Mazzotti E, Pasquini P. Prevalence and correlates of suicidal ideation among patients with skin disease [published online ahead of print January 18, 2006]. J Am Acad Dermatol. 2006;54:420-426.
8. Khan M, Naeem A, Mufti KA. Prevalence of mental health problems in acne patients. J Ayub Med Coll Abbottabad. 2001;13:7-8.
9. Gupta M, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 1998;139:846-850.
10. Humphreys F, Humphreys MS. Psychiatric morbidity and skin disease: what dermatologists think they see. Br J Dermatol. 1998;139:679-681.
11. Purvis D, Robinson E, Merry S, et al. Acne, anxiety, depression and suicide in teenagers: a cross-sectional survey of New Zealand secondary school students. J Paediatr Child Health. 2006;42:793-796.
12. Crosby AE, Cheltenham MP, Sacks JJ. Incidence of suicidal ideation and behavior in the United States, 1994. Suicide Life Threat Behav. 1999;29:131-140.
13. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. Br J Dermatol. 1997;137:246-250.
14. ergusson DM, Woodward LJ, Horwood LJ. Risk factors and life processes associated with the onset of suicidal behavior during adolescence and early adulthood. Psychol Med. 2000;30:23-39.
15. Beautrais AL, Joyce PR, Mulder T. Personality traits and cognitive styles as risk factors for serious suicide attempts among young people. Suicide Life Threat Behav. 1999;29:37-47.
16. Benjaminsen S, Krarup G, Lauritse R. Personality, parental rearing behavior and parental loss in attempted suicide: a comparative study. Acta Psychiatr Scand. 1990;82:389-397.
17. De Wilde EJ, Kienhorst IC, Diekstra RF, et al. The specificity of psychological characteristics of adolescent suicide attempters. J Am Acad Child Adolesc Psychiatry. 1993;32:51-59.
18. Shaffer D. Suicide in childhood and early adolescence. J Child Psychol Psychiatry. 1974;15:275-291.
19. Brent DA, Perper JA, Moritz G, et al. Psychiatric risk factors for adolescent suicide: a case-control study. J Am Acad Child Adolesc Psychiatry. 1993;32:521-529.
20. Brent DA, Kolko DJ, Wartella ME, et al. Adolescent psychiatric inpatients' risk of suicide attempt at 6-month follow-up. J Am Acad Child Adolesc Psychiatry. 1993;32:95-105.
21. Marttunen MJ, Aro HM, Lönnqvist JK. Adolescence and suicide: a review of psychological autopsy studies. Eur Child Adolesc Psychiatry. 1993;2:10-18.
22. Gould MS, Fisher P, Parides M, et al. Psychosocial risk factors of child and adolescent completed suicide. Arch Gen Psychiatry. 1996;53:1155-1162.
23. McKeown RE, Garrison CZ, Cuffe SP, et al. Incidence and predictors of suicidal behaviours in a longitudinal sample of young adolescents. J Am Acad Child Adolesc Psychiatry. 1998;37:612-619.
24. Gupta MA, Gupta AK, Schork NJ. Psychosomatic study of self-excoriative behavior among male acne patients: preliminary observations. Int J Dermatol. 1994;33:846-848.
25. Hintikka J, Viinamäki H, Tanskanen A, et al. Suicidal ideation and parasuicide in the Finnish general population. Acta Psychiatr Scand. 1998;98:23-27.
26. Kjøller M, Helweg-Larsen M. Suicidal ideation and suicide attempts among adult Danes. Scand J Public Health. 2000;28:54-61.
27. Pearl A, Arroll B, Lello J, et al. The impact of acne: a study of adolescents' attitudes, perception and knowledge. N Z Med J. 1998;1111:269-271.
28. Hughes JE, Barraclough BM, Hamblin LG, et al. Psychiatric symptoms in dermatology patients. Br J Psychiatry. 1983;143:51-54.
29. Cunliffe W, Hull SM, Hughes BR. The benefit of isotretinoin in the severely depressed/dysmorphophobic patient. Second International Congress on Psychiatry and Dermatology University of Leeds, UK (Abstract), 1989.
30. Niemeier V, Kupfer J, Demmelbauer-Ebner M, et al. Coping with acne vulgaris: evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology. 1998;196:108-115.
31. Kenyon FE. Psychosomatic aspects of acne. Br J Dermatol. 1966;78:344-351.
32. Angold A, Costello EJ, Worthman CM. Puberty and depression: the roles of age, pubertal status and pubertal timing. Psychol Med. 1998;28:51-61.
33. Bowe WP, Leyden JJ, Crerand CE, et al. Body dysmorphic disorder symptoms among patients with acne vulgaris [published online ahead of print May 10, 2007]. J Am Acad Dermatol. 2007;57:222-230.
34. Nestor MS. The use of photodynamic therapy for treatment of acne vulgaris. Dermatol Clin. 2007;25:47-57.
35. Welp K, Gieler U. Acne vulgaris: morphologic, endocrinologic, and psychosomatic aspects [in German]. Z Hautkr. 1990;65:1139-1145.
36. Gupta MA, Gupta AK. Olanzapine may be an effective adjunctive therapy in the management of acne excoriée: a case report. J Cutan Med Surg. 2001;5:25-27.
37. Kelly MW, Myers CW. Clomipramine: a tricyclic antidepressant effective in obsessive compulsive disorder. DICP. 1990;24:739-743.
38. Fontaine R, Chouinard G. An open clinical trial of fluoxetine in the treatment of obsessive-compulsive disorder. J Clin Psychopharmacol. 1986;6:98-101.
39. Moussavian H. Improvement of acne in depressed patients treated with paroxetine. J Am Acad Child Adolesc Psychiatry. 2001;40:505-506.
40. Gray P. The nature of therapeutic action in psychoanalysis. J Am Psychoanal Assoc. 1990;38:1083-1097.
41. Blatt SJ, Behrends RS. Internalization, separation-individuation, and the nature of therapeutic action. Int J Psychoanal. 1987;68(pt 2):279-298.
42. Hughes H, Brown BW, Lawlis GF, et al. Treatment of acne vulgaris by biofeedback relaxation and cognitive imagery. J Psychosom Res. 1983;27:185-191.
43. Kent A, Drummond LM. Acne excoriée-a case report of treatment using habit reversal. Clin Exp Dermatol. 1989;14:163-164.
44. Koblenzer C. Psychotherapy for intractable inflammatory dermatoses. J Am Acad Dermatol. 1995;32:609-612.
45. Arnold LM, Auchenbach MB, McElroy SL. Psychogenic excoriation. clinical features, proposed diagnostic criteria, epidemiology and approaches to treatment. CNS Drugs. 2001;15:351-359.
46. Marqueling AL, Zane LT. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg. 2005;24:92-102.
47. Chia CY, Lane W, Chibnall J, et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol. 2005;141:557-560.
48. Magin P, Pond D, Smith W. Isotretinoin, depression and suicide: a review of the evidence. Br J Gen Pract. 2005;55:134-138.
49. Ng CH, Schweitzer I. The association between depression and isotretinoin use in acne. Aust N Z J Psychiatry. 2003;37:78-84.
50. Ng CH, Tam MM, Celi E, et al. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol. 2002;43:262-268.
51. Gupta MA, Gupta AK, Schork NJ, et al. Psychiatric aspects of the treatment of mild to moderate facial acne. Some preliminary observations. Int J Dermatol. 1990;29:719-721.
52. Gupta MA, Gupta AK. The use of antidepressant drugs in dermatology. J Eur Acad Dermatol Venereol. 2001;15:512-518.
53. Wu SF, Kinder BN, Trunnel TN, et al. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. J Am Acad Dermatol. 1988;18(2, pt 1):325-333.
54. Rubinow D, Peck GL, Squillace KM, et al. Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol. 1987;17:25-32.
55. Newton JN, Mallon E, Klassen A, et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol. 1997;137:563-567.
56. Hull SM, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphophobic acne patient. Clin Exp Dermatol. 1991;16:210-211.
57. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol. 2000;136:1231-1236.
58. Ferahbas A, Turan MT, Esel E, et al. A pilot study evaluating anxiety and depressive scores in acne patients treated with isotretinoin. J Dermatolog Treat. 2004;15:153-155.
59. Motley RJ, Finlay AY. How much disability is caused by acne? Clin Exp Dermatol. 1989;14:194-198.
60. Azoulay L, Blais L, Koren G, et al. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study. J Clin Psychiatry. 2008;69:526-532.
61. Bigby M. Does isotretinoin increase the risk of depression. Arch Dermatol. 2008;144:1197-1199, 1234-1235.